Arthur C. Santora II - Chief Medical Officer at Entera Bio Ltd.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
ENTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Arthur C. Santora II since 12 Aug 2025

Reported holdings for Arthur C. Santora II in Entera Bio Ltd.

Form 4 holding Chief Medical Officer

Entera Bio Ltd.

Security class
Stock Option (right to buy)
Shares / value
35,000
Estimated value
Report date
24 Apr 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount

Transaction history for Arthur C. Santora II in Entera Bio Ltd.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .